HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments and reagents for molecular profiling applications announced it has joined the Worldwide Innovative Networking (WIN) Consortium in personalized cancer medicine as an official technology partner.
Monthly Archives: August 2015
CTX Acquires Promising Proprietary Drug Delivery Assets
CTX Technology Inc., based in Tucson, Arizona, has acquired the intellectual property, formulations and related data of Convoy Therapeutics Inc.
ULTHERA ANNOUNCES TWO YEAR FDA CLEARANCE FOR CELLFINA™ SYSTEM
Cellfina™ Earns Longest FDA Clearance for a Cellulite Treatment
Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol for the Treatment of Infantile Spasms
Insys Therapeutics, Inc. (NASDAQ:INSY) (“Insys” or “the Company”) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to its pharmaceutical cannabidiol (CBD) candidate for the treatment of infantile spasms (IS).Continue reading
Helios Scholars at TGen graduate from summer biomedical research training program
45 students from across Arizona featured at symposium sponsored by Helios Education FoundationContinue reading